Thursday 22 October 2020
Home Tags Glenmark


COVID-19: Glenmark launches medicine at Rs 103 per tablet

Glenmark was the first company in India to receive the drug regulator's approval to conduct phase-3 clinical trial of Favipiravir antiviral tablets for COVID-19 patients

Follow Sirf News on social media:

Most Popular